Omadacycline

Name: Omadacycline | 389139-89-3
Brand: US-CATO
SKU: S57C1886510_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C1886510_10_MG

Vendor: US-CATO

Product Information

Product Name

Omadacycline

Brand Name

US-CATO

Product Number

C1886510

CAS

389139-89-3

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

54697325

IUPAC Name

(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-(2,2-dimethylpropylamino)methyl-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

InChI Key

VJYKVCURWJGLPG-IQZGDKDPSA-N

SMILES

CC(C)(C)CNCC1=CC(=C2CC@H3CC@H4C@@H(C(=O)C(=C(C@4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C

References Data Source From Pubchem

Genomic characterization of multidrug-resistant Klebsiella pneumoniae from an outbreak in Northeastern Brazil: mechanisms of virulence and resistance

Publication Name: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]

Publication Date: 2026-02-25

DOI: 10.1007/s42770-026-01882-3

Targeted next-generation sequencing improves diagnosis and antimicrobial stewardship in Chlamydia psittaci pneumonia

Publication Name: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Publication Date: 2026-02-12

DOI: 10.1007/s10096-026-05404-9

Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current Strategies

Publication Name: Clinical Pharmacokinetics

Publication Date: 2026-02-08

DOI: 10.1007/s40262-026-01620-w

Addendum: ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro

Publication Name: Nature Microbiology

Publication Date: 2026-02-06

DOI: 10.1038/s41564-026-02267-w

Malaria: a review on its current epidemiological status and management strategies

Publication Name: Malaria Journal

Publication Date: 2026-02-04

DOI: 10.1186/s12936-025-05748-1

Omadacycline

Product Information

General Information

References Data Source From Pubchem

Genomic characterization of multidrug-resistant Klebsiella pneumoniae from an outbreak in Northeastern Brazil: mechanisms of virulence and resistance

Targeted next-generation sequencing improves diagnosis and antimicrobial stewardship in Chlamydia psittaci pneumonia

Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current Strategies

Addendum: ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro

Malaria: a review on its current epidemiological status and management strategies

Omadacycline

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Omadacycline

Product Information

General Information

References Data Source From Pubchem

Genomic characterization of multidrug-resistant Klebsiella pneumoniae from an outbreak in Northeastern Brazil: mechanisms of virulence and resistance

Targeted next-generation sequencing improves diagnosis and antimicrobial stewardship in Chlamydia psittaci pneumonia

Methodologies for Population Pharmacokinetic Modeling of Target-Site Drug Exposure: A Narrative Review of Current Strategies

Addendum: ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro

Malaria: a review on its current epidemiological status and management strategies

Omadacycline

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register